15,666 Shares in Astrana Health, Inc. (NASDAQ:ASTH) Purchased by Sherbrooke Park Advisers LLC

Sherbrooke Park Advisers LLC acquired a new position in shares of Astrana Health, Inc. (NASDAQ:ASTH - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 15,666 shares of the company's stock, valued at approximately $494,000.

A number of other hedge funds have also bought and sold shares of ASTH. Principal Financial Group Inc. purchased a new position in shares of Astrana Health during the 3rd quarter worth about $13,383,000. 325 Capital LLC grew its stake in shares of Astrana Health by 30.3% during the fourth quarter. 325 Capital LLC now owns 886,916 shares of the company's stock valued at $27,964,000 after buying an additional 206,009 shares during the last quarter. Renaissance Technologies LLC raised its holdings in shares of Astrana Health by 217.6% in the fourth quarter. Renaissance Technologies LLC now owns 217,900 shares of the company's stock worth $6,870,000 after buying an additional 149,300 shares during the period. Royce & Associates LP lifted its stake in shares of Astrana Health by 122.3% during the 4th quarter. Royce & Associates LP now owns 255,552 shares of the company's stock worth $8,058,000 after acquiring an additional 140,584 shares during the last quarter. Finally, Dimensional Fund Advisors LP increased its stake in Astrana Health by 10.7% in the fourth quarter. Dimensional Fund Advisors LP now owns 1,045,540 shares of the company's stock worth $32,968,000 after purchasing an additional 101,192 shares during the period. Institutional investors own 52.77% of the company's stock.

Wall Street Analyst Weigh In

A number of equities research analysts recently weighed in on the stock. Barclays began coverage on shares of Astrana Health in a report on Tuesday, April 1st. They set an "equal weight" rating and a $36.00 price objective for the company. Robert W. Baird cut their price target on Astrana Health from $86.00 to $50.00 and set an "outperform" rating on the stock in a research note on Monday, March 3rd. Bank of America cut their target price on shares of Astrana Health from $55.00 to $49.00 and set a "buy" rating on the stock in a research report on Tuesday, March 4th. Stifel Nicolaus cut their price target on Astrana Health from $70.00 to $56.00 and set a "buy" rating on the stock in a report on Thursday, February 20th. Finally, Truist Financial dropped their price objective on Astrana Health from $50.00 to $46.00 and set a "buy" rating on the stock in a research report on Tuesday, March 18th. Three analysts have rated the stock with a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average target price of $53.29.

Astrana Health Stock Performance

Astrana Health stock traded down $0.52 during mid-day trading on Friday, reaching $23.95. 47,249 shares of the company traded hands, compared to its average volume of 289,322. The company has a market capitalization of $1.34 billion, a price-to-earnings ratio of 18.44, a price-to-earnings-growth ratio of 1.37 and a beta of 1.00. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.91 and a quick ratio of 1.91. Astrana Health, Inc. has a fifty-two week low of $23.12 and a fifty-two week high of $63.20. The firm's fifty day moving average is $30.50 and its two-hundred day moving average is $34.63.

Astrana Health (NASDAQ:ASTH - Get Free Report) last announced its quarterly earnings data on Thursday, May 8th. The company reported $0.14 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.23 by ($0.09). Astrana Health had a return on equity of 9.37% and a net margin of 3.63%. The firm had revenue of $620.39 million during the quarter, compared to analysts' expectations of $628.11 million. During the same quarter in the previous year, the business earned $0.31 earnings per share. The company's revenue for the quarter was up 53.4% compared to the same quarter last year. On average, equities research analysts expect that Astrana Health, Inc. will post 1.15 earnings per share for the current fiscal year.

Astrana Health Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.